1. Home
  2. WAL vs PRAX Comparison

WAL vs PRAX Comparison

Compare WAL & PRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Western Alliance Bancorporation (DE)

WAL

Western Alliance Bancorporation (DE)

HOLD

Current Price

$66.80

Market Cap

9.6B

Sector

Finance

ML Signal

HOLD

Logo Praxis Precision Medicines Inc.

PRAX

Praxis Precision Medicines Inc.

HOLD

Current Price

$289.43

Market Cap

9.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WAL
PRAX
Founded
1994
2015
Country
United States
United States
Employees
3524
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.6B
9.6B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
WAL
PRAX
Price
$66.80
$289.43
Analyst Decision
Buy
Strong Buy
Analyst Count
16
15
Target Price
$96.73
$572.13
AVG Volume (30 Days)
1.7M
308.0K
Earning Date
04-20-2026
05-01-2026
Dividend Yield
2.52%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$20.25
N/A
Revenue Next Year
$8.09
$6,395.88
P/E Ratio
$10.88
N/A
Revenue Growth
N/A
N/A
52 Week Low
$57.05
$26.70
52 Week High
$97.23
$354.87

Technical Indicators

Market Signals
Indicator
WAL
PRAX
Relative Strength Index (RSI) 24.06 37.95
Support Level N/A $266.93
Resistance Level $87.53 $322.32
Average True Range (ATR) 3.17 16.36
MACD -1.20 -4.02
Stochastic Oscillator 0.44 4.20

Price Performance

Historical Comparison
WAL
PRAX

About WAL Western Alliance Bancorporation (DE)

Western Alliance Bancorp provides a full spectrum of customized loan, deposit, and treasury management capabilities, including funds transfer and other digital payment offerings. The company's reportable segments are Commercial segment includes provides commercial banking and treasury management products and services to small and middle-market businesses, specialized banking services to sophisticated commercial institutions and investors within niche industries, as well as financial services to the real estate industry. Consumer Related segment offers both commercial banking services to enterprises in consumer-related sectors and consumer banking services, such as residential mortgage banking and Corporate & Other.

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.

Share on Social Networks: